Moderna said it will apply for U.S. and European emergency authorization of its COVID-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1%…

Read more »

The post Moderna to Seek U.S., EU Emergency Authorization After COVID-19 Vaccine 94.1% Effective appeared first on Hamodia.

In related news:

  1. U.N.: COVID-19 Deaths for People Over 80 Are Five Times Average
  2. Zoos Turn to Social Media to Delight, Raise Money Amid Virus
  3. Three Russian Doctors Fall From Hospital Windows During Pandemic
  4. ‘Foretaste’ of Brexit: Virus Cuts Off Much of U.K. Farm Labor
  5. Hong Kong Tightens Coronavirus Restrictions as Cases Hit Record